The income result essentially met the market bar. Net investment income was $0.45 per share versus a published consensus of approximately $0.45, making this an in-line quarter rather than a meaningful beat. The company’s own comparison shows NII per share declined from $0.47 in the prior quarter.
| Metric | Q2 2026 | Prior comparison | Market read |
|---|---|---|---|
| Net investment income/share | $0.45 (Financial Highlights) | $0.47 in Q1 2026 (Financial Highlights) | ~$0.45 consensus |
| Net asset value/share | $19.50 (Financial Highlights) | $19.81 in Q1 2026 (Financial Highlights) | Down $0.31 sequentially |
| Regular dividend/share | $0.45 (Financial Highlights) | $0.45 in Q1 2026 (Financial Highlights) | Covered, but with no excess cushion |
| Weighted-average yield on debt investments | 9.1% at cost; 9.4% at fair value (Portfolio and Investment Activity) | 9.3% and 9.5% in Q1 2026 | Lower |
| Non-accrual exposure | 2.9% of investments at amortized cost across seven companies (Portfolio and Investment Activity) | Not provided in the filing’s Q1 comparison | Credit pressure visible |
| Net realized and unrealized gain/loss per share | $(0.36) (Selected Financial Highlights) | $(0.52) in Q1 2026 | Less severe, but still negative |
The underlying credit picture weakened despite the in-line income headline. Investment income was nearly flat, but expenses rose to $49.8 million from $47.7 million, while the company specifically attributed the income decline to positions placed on non-accrual. 〔0〕 The filing also reports seven non-accrual portfolio companies representing approximately 2.9% of investments at amortized cost. 〔1〕
NAV erosion is the more important miss versus the clean income number. NAV fell from $19.81 to $19.50 per share, reflecting $22.8 million of unrealized depreciation and $7.4 million of realized losses. The portfolio also shrank to $3.55 billion from $3.67 billion, while the weighted-average yield declined, suggesting the quarter was shaped more by credit marks, repayments and lower earning assets than by growth.
Capital remains controlled, but the dividend is only exactly covered. Debt-to-equity improved slightly to 1.21x from 1.22x, with $1.47 billion of credit-facility availability and $71.6 million of unrestricted cash and liquid investments. However, the $0.45 dividend equals quarterly NII per share, leaving no reported coverage surplus. The post-quarter issuance of $350 million of 6.10% notes due July 2031 extends funding duration, but also adds fixed-cost capital.
Net read: in line on earnings, mixed on quality. The market received the expected $0.45 of recurring income, but worsening non-accruals, lower yields and a declining NAV make this a weaker-quality in-line quarter rather than a clean positive surprise.
Read the original 8-K on SEC EDGAR ↗